Merck prevails in Fosamax liability suit; Roche chief scouting for buyouts, rights;

  @FiercePharma: Bayer to cut 4,500 jobs in global overhaul. Story | Follow @FiercePharma

> Merck won one another of several bellwether product-liability cases involving its osteoporosis drug Fosamax. Item

> Roche is looking for opportunities to make small-to-medium-sized acquisitions or to gain rights to new products, SonntagsZeitung reported, citing CEO Severin Schwan. News

> Genzyme expects to meet a Nov. 28 deadline to move finishing and filling operations for U.S. products from its Allston, Massachusetts plant. Article

Special Report: Top 5 Game-Changing Drug Delivery Technologies. Report

> French drugmaker Sanofi-Aventis's bid for U.S. biotech group Genzyme would not affect Sanofi's dividend policy in the short term, CFO Jerome Contamine said. Report

> China's market for diabetes-related drugs will almost triple to $2 billion over the next decade, spurred by increased prevalence of the disease, Datamonitor Group said. Story

Special Report: Pharma manufacturing consent decrees: 16 black holes. Item 

> Indian generics maker Dr. Reddy's Laboratories said it has launched a generic version of AstraZeneca's asthma tablet Accolate in the U.S. after receiving a favorable court decision. Article

> Globalization is the main challenge to drug supply chain security, according to USP scientist Desmond Hunt, who says greater collaboration is the key to maintaining product integrity. News

Special Report: Biggest Battles in Biopharma. Report

Biotech News

 @FierceBiotech: GSK: Not interested in Gemzyme deal. Story | Follow @FierceBiotech

> Regeneron AMD drug beats Lucentis on dosing in Phase III. Report 

> Celldex touts promise of PhII brain cancer vaccine data. News 

> Genzyme proffers milestone-based deal to potential suitors. Article 

Biotech IT News

> Pfizer recruits academia as research partner. Story

> iPhone apps aid clinic workflow, management. Report

> Researchers tap online forums for subjects, insights. Article 

> Biolex reveals ePRO surprise, selection process. Item 

> Studies: a "yea" and a "nay" for pharma Internet sites. News

> Cloud indecision has its price. Article 

And Finally... Removing cough and cold medicines for very young children from store shelves led to a big decline in emergency room visits for bad reactions to the drugs, government research found. Report